Spasenija Savic Prince

A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

Daniela S. Thommen, Viktor H. Koelzer, Petra Herzig et al. · Nature Medicine · 2018 · 1.1K citations · Full text

Cancer Immunosurveillance, Non-small-cell Lung Cancer, Pd-1 Blockade +8

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Daniela S. Thommen, Jens Schreiner, Philipp Müller et al. · Cancer Immunology Research · 2015 · 378 citations

Increased Dysfunction, T-regulatory Cell, Immunology +18

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial

Sacha I. Rothschild, Alfred Zippelius, E.I. Eboulet et al. · Journal of Clinical Oncology · 2021 · 336 citations

Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer

Ilaria Alborelli, Katharina Leonards, Sacha I. Rothschild et al. · The Journal of Pathology · 2019 · 112 citations · Full text

Targeted Ngs, Immunology, Pathology +18

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity

Kea Martin, Philipp Müller, Jens Schreiner et al. · Cancer Immunology Immunotherapy · 2014 · 74 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +9